HomeCompareEQGPF vs PFE

EQGPF vs PFE: Dividend Comparison 2026

EQGPF yields 2.07% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQGPF wins by $1.59M in total portfolio value
10 years
EQGPF
EQGPF
● Live price
2.07%
Share price
$78.81
Annual div
$1.63
5Y div CAGR
74.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.64M
Annual income
$1,214,065.53
Full EQGPF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — EQGPF vs PFE

📍 EQGPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEQGPFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EQGPF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EQGPF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EQGPF
Annual income on $10K today (after 15% tax)
$176.23/yr
After 10yr DRIP, annual income (after tax)
$1,031,955.70/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, EQGPF beats the other by $1,009,635.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EQGPF + PFE for your $10,000?

EQGPF: 50%PFE: 50%
100% PFE50/50100% EQGPF
Portfolio after 10yr
$846.8K
Annual income
$620,162.13/yr
Blended yield
73.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

EQGPF
Analyst Ratings
7
Buy
Consensus: Buy
Altman Z
-0.5
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EQGPF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEQGPFPFE
Forward yield2.07%6.13%
Annual dividend / share$1.63$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR74.9%13.2%
Portfolio after 10y$1.64M$49.6K
Annual income after 10y$1,214,065.53$26,258.71
Total dividends collected$1.58M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: EQGPF vs PFE ($10,000, DRIP)

YearEQGPF PortfolioEQGPF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,063$362.62$9,153$693.39+$1.9KEQGPF
2$12,493$655.72$8,593$849.25+$3.9KEQGPF
3$14,578$1,210.38$8,336$1,066.78+$6.2KEQGPF
4$17,907$2,308.64$8,437$1,384.80+$9.5KEQGPF
5$23,796$4,635.44$9,013$1,875.40+$14.8KEQGPF
6$35,530$10,068.83$10,306$2,680.72+$25.2KEQGPF
7$62,592$24,574.52$12,820$4,101.38+$49.8KEQGPF
8$137,737$70,763.89$17,673$6,826.70+$120.1KEQGPF
9$401,916$254,537.36$27,543$12,591.86+$374.4KEQGPF
10$1,644,116$1,214,065.53$49,560$26,258.71+$1.59MEQGPF

EQGPF vs PFE: Complete Analysis 2026

EQGPFStock

EQB Inc., through its subsidiary, Equitable Bank, provides personal and commercial banking services to retail and commercial customers in Canada. The company accepts term deposits and guaranteed investment certificates, high interest savings accounts, tax-free savings accounts, and institutional deposit notes, as well as specialized financing solutions. Its loan products include residential mortgages; equipment loans; home equity, cash surrender value, and commercial equity lines of credit; business enterprise solutions comprising mixed use, multi-residential properties, retail spaces, office condominiums, and industrial buildings; and asset repositioning, inventory, term, and construction loans. The company also offers digital banking services, as well as a range of banking solutions, including international money transfers, US dollar accounts, and a suite of registered products. The company was formerly known as Equitable Group Inc. and changed its name to EQB Inc. in June 2022. EQB Inc. was founded in 1970 and is headquartered in Toronto, Canada.

Full EQGPF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this EQGPF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EQGPF vs SCHDEQGPF vs JEPIEQGPF vs OEQGPF vs KOEQGPF vs MAINEQGPF vs JNJEQGPF vs MRKEQGPF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.